Skip to main content
USAID

USAID's NTD Program
USAID's NTD Program

Neglected Tropical Diseases in Burkina Faso

Photo: A map of Burkina Faso.

In all countries supported by USAID’s NTD Program, country ownership of the Program is a core principle and is critical to successful implementation and long-term sustainability.

USAID support for NTD control in Burkina Faso is provided through a cooperative agreement with RTI, with a sub-grant to Schistosomiasis Control Initiative (SCI). SCI works alongside the Burkina Faso government and the Ministry of Health, and also engages with a wide range of dedicated local stakeholders, including the World Health Organization – Burkina Faso, Réseau International Schistosomoses Environnement Amenagements et Lutte and the Liverpool NTD Support Center.

USAID’s support for integrated NTD control in Burkina Faso began with the launch of a national stakeholders meeting in January 2007. Results of activities carried out with United States Congressional funding in Burkina Faso to date* include:

  • Mass Drug Administration
    • First round of treatment was carried out in:
      • August 2007 in three districts
      • December 2007-July 2008 in 29 districts
    • Second round of treatment was carried out in:
      • December 2007-July 2008 in 32 districts
    • Third round planned for January-July 2009 in 32 districts
  • Treatment
    • A total of 10.41 million treatments have been provided since 2007
    • 1.01 million people were treated in August 2007
    • 4.42 million people were treated from December 2007-July 2008
  • Mapping
    • 33 districts were mapped for trachoma (blinding eye infection) prevalence in 2007
    • 16 districts were mapped for trachoma (blinding eye infection) prevalence in 2008
  • Training
    • 3,156 people were trained to deliver integrated treatment in 2007
    • 50,283 people were trained to deliver integrated treatment in 2008

Upcoming Program Activities
The Program will continue to sponsor the above mentioned key activities. In the upcoming year, it is expected that through the Program:

  • 8.5 million Burkinabe will receive needed treatments in 32 districts of the country

*Updated February 2009